mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
erastin |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.4 |
mRNA |
sitagliptin |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.4 |
mRNA |
Obatoclax Mesylate |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.4 |
mRNA |
GSK525762A |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.4 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.5 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.5 |